anomaly has not been proven in man. The detection of position effects might be possi61e in man by the analysis of apparently balanced translocations and a search for correlations between specific breakpoints and phenotypic abnormalities. A dysmorphic and mentally retarded boy has been found presumably carrying a de novo balanced translocation which involves the long arms of chromosomes 13 and 18. Breakpoint mapping the long arms of the chromosomes 13 and 18 has revealed presumptive evidence for a position effect in 18q2 1. 47,XX,+de1(13)(13pter + 13q12:) is associated with mental retardation, microophthalmy, enophthalmy, colobomata of iris and glaucoma of left eye, bilateral preauricular dimples, imperforate anus, rectovulvar fistual, and double left calyceal system. These observations permitted phenotypic mapping of the partial trisomic and monosomic segments in cases 1, 2, 3, and 5, which was not possible in case 4 because the patient also had a partial monosomy of chromosome 5. The deletions of the short arm of chromosome 13 (case 2) and long arm of chromosome Y (case 3) were considered to have no significant functional effect. It is widely accepted that male determinant genes must be present, at least in primordial germinal ce!ls, in order to determine testicular differentiation. However, exceptions have been reported, such as the existence of XX in apparently normal males and in the majority of true hermaphrodites. Several theories have been advanced to explain the existence of testicular tissue in the absence of a Y chromosome, but they have not been confirmed cytologically. The present work attempts to detect the presence of a Y chromosome by the quinacrine fluorescence technique in histologic sections of gonads from three patients with true hermaphroditism and somatic cell karyotypes 46,XX. Typical fluorescence of the Y chromosome was found in the testicular tissue from the three patients, indicating the existence of the Y chromosome in gonadal tissue. These findings strongly support the hypothesis that a Y chromosome is necessary for testicular differentiation. (Methods Enzymol., 28: 862 (1973)). In those cases where the results were doubtful, especially in the pregnant women (6), the hexosaminidase A levels were also tested in the leukocyte, according to the method described by Kaback and Zeiger (Advan. Exp.
It is widely accepted that male determinant genes must be present, at least in primordial germinal ce!ls, in order to determine testicular differentiation. However, exceptions have been reported, such as the existence of XX in apparently normal males and in the majority of true hermaphrodites. Several theories have been advanced to explain the existence of testicular tissue in the absence of a Y chromosome, but they have not been confirmed cytologically. The present work attempts to detect the presence of a Y chromosome by the quinacrine fluorescence technique in histologic sections of gonads from three patients with true hermaphroditism and somatic cell karyotypes 46,XX. Typical fluorescence of the Y chromosome was found in the testicular tissue from the three patients, indicating the existence of the Y chromosome in gonadal tissue. These findings strongly support the hypothesis that a Y chromosome is necessary for testicular differentiation. (Methods Enzymol., 28: 862 (1973) ). In those cases where the results were doubtful, especially in the pregnant women (6), the hexosaminidase A levels were also tested in the leukocyte, according to the method described by Kaback and Zeiger (Advan. Exp. Med. Biol., 19: 13 (1972) ' In the pregnant women in which results from 15.6-35.0% of serum hexosaminidase A were found, the leukocyte tests showed levels within the limits of normal homozygotes.
Partial Trisomies and Deletions of Chromosome 13

Comments:
The high incidence of heterozygote carriers of TaySachs disease in Ashkenazi Jews (1:30), emphasized once more by this investigation, justifies the population screening for these heterozygotes, particularly among Jews, in order to offer genetic counseling and try to prevent further cases of Tay-Sachs disease. Determinations of anti-HGH antibody were performed by radioimmunoassay in 57 patients with pituitary insufficiency who had been treated with human growth hormone (HGH). Antibodies were not detected in 38 patients, 10 had low antibody titers (1: 15-1: 120), 4 medium titers (1: 120-1:960), and 5 high titers (of 1:960). In 42 patients, antibody titers could be correlated with growth velocity during HGH treatment. An adequate growth velocity was observed in 25 of 27 patients with negative titers, 5 of 7 with low titers, 3 of 4 with medium titers, and 1 of 4 with high
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